CD19-targeted chimeric antigen receptor (CAR)-T cell therapyrapcabtagene autoleucelcyclophosphamideDiffuse cutaneous systemic sclerosis (dcSSc)fludarabineNovartis Pharma AGdcSSc
… address clinical manifestations or modify disease progression. CD19-targeted chimeric antigen receptor (CAR)-T cell therapy shows promise, with the potential to induce deep and sustained …